Results 41 to 50 of about 344,829 (184)

Vaccine [PDF]

The U.S. Food and Drug Administration authorized use of mRNA COVID-19 bivalent booster vaccines on August 31, 2022. Currently, CDC's clinical guidance states that COVID-19 and other vaccines may be administered simultaneously.

core   +4 more sources

Immunogenic Cross-Reactivity between Goose and Muscovy Duck Parvoviruses: Evaluation of Cross-Protection Provided by Mono- or Bivalent Vaccine

, 2022
To investigate the immunogenic cross reactivity between goose parvovirus (GPV) and Muscovy duck parvovirus (MDPV), cross-neutralization was carried out with serum samples collected from birds after infection with one of the two waterfowl parvoviruses ...
Vilmos Palya, Felföldi, Balázs, Palya, Vilmos, Balázs Felföldi, Zolnai, Anna, Anna Zolnai   +5 more
core   +1 more source

Mapping the Social Network Structure and Composition of Black Individuals With Rheumatic and Musculoskeletal Conditions

Arthritis Care &Research, EarlyView.
Objective Our objective was to describe the social networks of Black individuals with rheumatic and musculoskeletal conditions and understand the clustering of health‐related behaviors to inform future community‐based, peer‐led interventions. Methods We used an adapted Personal Network Survey for Clinical Research (PERSNET) to map the personal social ...
Taussia Boadi, Amar Dhand, Leah Santacroce, Neil Pillai, Komel Safdar, Mia T. Chandler, Ariel Childs, Monica Crespo‐Bosque, Gina Curry, Mary Dollear, Alice Eggleston, Daniel Erickson, Dieufort Fleurissaint, Denice Garrett, Gail Granville, Tyler Green, Magdalena Hamielec, Elena Losina, Karen Mancera‐Cuevas, Mary Ann Nelson, Chisa Nosamiefan, Bisola Ojikutu, Tonya S. Roberson, Mary Beth Son, Marie Jacques Toussaint, Michael York, Rosalind Ramsey‐Goldman, Candace H. Feldman   +27 more
wiley   +1 more source

Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationResearch in context

EBioMedicine
Summary: Background: Bivalent SARS-CoV-2 vaccines were developed to counter increasing susceptibility to emerging SARS-CoV-2 variants. We evaluated the durability of immunity and protection following first bivalent vaccination among nursing home ...
Stefan Gravenstein, Frank DeVone, Oladayo A. Oyebanji, Yasin Abul, Yi Cao, Philip A. Chan, Christopher W. Halladay, James L. Rudolph, Clare Nugent, Jürgen Bosch, Christopher L. King, Brigid M. Wilson, Alejandro B. Balazs, Elizabeth M. White, David H. Canaday, Kevin W. McConeghy   +15 more
doaj   +1 more source

Nanomaterials for Allergy Diagnosis and Treatment: Advances, Opportunities and Translational Challenges

Advanced Science, EarlyView.
Nanomaterials offer dual applications in allergy management. For diagnosis, nanomaterials enhance analytical sensitivity and improve detection in specific IgE and functional assays such as the basophil activation test (BAT). For allergen‐specific immunotherapy, nanomaterials enable allergen masking and controlled release, and effectively modulate the ...
Madiha Habib, Shan Jiang, Joyce ZX Lee, CW Lim, HL Yeung, Nicki YH Leung, Patrick SC Leung, Ting F Leung, Christine YY Wai   +8 more
wiley   +1 more source

Age-associated hyper-methylated regions in the human brain overlap with bivalent chromatin domains [PDF]

, 2012
Recent associations between age-related differentially methylated sites and bivalently marked chromatin domains have implicated a role for these genomic regions in aging and age-related diseases. However, the overlap between such epigenetic modifications
Giulio Disanto, Giovannoni Gavin, Gavin Giovannoni, Ramagopalan Sreeram V., Sandve, GK, Watson Corey T., Ramagopalan, SV, Watson, CT, Sandve Geir Kjetil, Ramagopalan, Sreeram, Sreeram V Ramagopalan, Disanto Giulio, Breden Felix, Corey T Watson, Felix Breden, Breden, F, Giovannoni, G, Geir Kjetil Sandve, Disanto, G   +18 more
core   +2 more sources

Assessment of Stability of Chemical Cholera Vaccine in a New Primary Packaging

Проблемы особо опасных инфекций, 2023
The bivalent chemical cholera vaccine is the only drug for the prevention of cholera registered in the Russian Federation. The vaccine has been produced in glass bottles containing 210 tablets.
O. V. Gromova, S. A. Vorob’eva, O. A. Volokh, O. D. Klokova, L. F. Livanova, N. I. Belyakova, E. Z. Popova, O. A. Lobovikova, I. V. Shul’gina, I. G. Shvidenko, A. K. Nikiforov   +10 more
doaj   +1 more source

Disease‐Stage Synchronized Nanozyme Therapy for Polymicrobial Sepsis through Adaptive Catalytic and Immune Reprogramming

Advanced Science, EarlyView.
A disease‐stage synchronized nanozyme platform is developed to treat polymicrobial sepsis by adapting its functions to changing infection environments. The system eliminates multidrug‐resistant bacteria during early infection while reducing inflammation and restoring immune balance during recovery, providing an integrated strategy for infection control
Anlai Zou, Xiaoxue Zhu, Runhan Zhu, Chengchu Xue, Qinyu Zhang, Mengke Li, Ting Yu, Yuzhen Gao, Zhi Ruan, Ying Fu, Yunlei Xianyu, Jun Zhang   +11 more
wiley   +1 more source

Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis

, 2020
Tuberculosis still claims more lives than any other pathogen, and a vaccine better than BCG is urgently needed. One of the challenges for novel TB vaccines is to protect against all Mycobacterium tuberculosis lineages, including the most virulent ones ...
권기웅, 신성재
core   +1 more source

Field evaluation of piglet vaccination with a Mycoplasma hyopneumoniae bacterin as compared to a ready-to-use product including porcine circovirus 2 and M. hyopneumoniae in a conventional French farrow-to-finish farm

Porcine Health Management, 2018
Background A controlled randomized trial was performed on a well-managed conventional French 180-sow farm. The trial compared the growth performances of piglets vaccinated at weaning (single shot) either with a commercial monovalent Mycoplasma ...
Didier Duivon, Isabelle Corrégé, Anne Hémonic, Martial Rigaut, David Roudaut, Rika Jolie   +5 more
doaj   +1 more source